We are live on ! Find out more

Pfizer

PFE

Market cap $158B

27.66 USD

+0.02

0.07%

At close Updated Sep 18, 4:00 PM EDT

Pre-market

After hours

27.62

-0.04

0.14%

1 day

0.07%

5 days

-1.5%

1 month

1.5%

3 months

9.72%

6 months

1.24%

Year to date

9.85%

1 year

14.53%

5 years

-37.42%

10 years

-13.37%

About: Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Employees: 75,000

Healthcare Drug Manufacturers - General

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 56.9%

Neutral 28.2%

Negative 14.9%

The Motley Fool

3 Dividend Stocks to Buy and Hold for 10 Years

Pfizer has a deep pipeline that could help improve its approved lineup and financial results over the medium term. Abbott Laboratories' core medical device business remains strong, and the company has attractive opportunities elsewhere.

3 Dividend Stocks to Buy and Hold for 10 Years

The Motley Fool

2 High-Yield Dividend Stocks to Buy and 1 to Avoid

Pfizer's free cash flow is not covering its dividend, and the company faces a patent cliff. Energy Transfer is one of the biggest beneficiaries of strong natural demand coming from the AI data center build-out.

2 High-Yield Dividend Stocks to Buy and 1 to Avoid

24/7 Wall Street

Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?

Pfizer has raised its dividend every year for over a decade, then something changed. Before you count on that 6% yield, find out what the payout's own behavior is quietly signaling about the company's financial confidence.

Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?

The Motley Fool

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

Pfizer's management remains firmly committed to maintaining the dividend. The company's growth portfolio is performing well.

Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.

24/7 Wall Street

How a Roth IRA Can Keep Thousands More of Your High-Yield Dividend Income Compounding

Where you hold a high-yield dividend stock matters almost as much as which one you pick, and for ordinary-income payers like BDCs and REITs, the wrong account quietly erodes a portion of every distribution before it ever compounds.

How a Roth IRA Can Keep Thousands More of Your High-Yield Dividend Income Compounding

Zacks Investment Research

4 Prostate Cancer Drug Stocks to Watch During Awareness Month

Pfizer, Novartis, Janux Therapeutics and Candel Therapeutics offer varied prostate-cancer exposure, with established drugs and clinical or regulatory catalysts.

4 Prostate Cancer Drug Stocks to Watch During Awareness Month

Zacks Investment Research

Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Alexandre de Germay, Chief International Commercial Officer, Executive Vice President, at the J.P. Morgan U.S. All Stars 2026 Conference on Tuesday, September 22, 2026 at 11:50 a.m. BST. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors.

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (PFE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Pfizer Inc. (PFE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Pfizer Inc. (PFE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage

Pfizer NYSE: PFE Chairman and Chief Executive Officer Albert Bourla said the drugmaker has addressed several major headwinds that weighed on investor attention, including policy uncertainty, declining COVID-19-related demand and upcoming losses of exclusivity for certain products.

Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage

See News Rankings

Price charts implemented using Lightweight Charts™